Profound Medical
PROF
16 hedge funds and large institutions have $21.8M invested in Profound Medical in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
16.44% more ownership
Funds ownership: 0% → 16.44% (+16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$8.99M |
| 2 |
GS
Gagnon Securities
New York
|
+$6.42M |
| 3 |
RA
Royce & Associates
New York
|
+$1.8M |
| 4 |
ERIM
Eagle Ridge Investment Management
Stamford,
Connecticut
|
+$277K |
| 5 |
Renaissance Technologies
New York
|
+$119K |
Top Sellers
PROF Hedge Fund Activity: Q4 2019 in Review
16 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2019, worth a combined $21.8M.
Buyers outnumbered sellers: 16 funds opened new PROF positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $8.99M.
- 16 institutional investors held Profound Medical (PROF) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $21.8M of Profound Medical stock for Q4 2019.
- 16 funds opened new Profound Medical positions in Q4 2019 and 0 closed out, a net change of +16 holders.
- The largest Profound Medical buyer in Q4 2019 was Fidelity International, an estimated $8.99M added.
Based on aggregated 13F filings for Q4 2019.